Federated Hermes’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,584
| Closed | -$167K | – | 2090 |
|
|
2023
Q2 | $167K | Sell |
3,584
-54,420
| -94% | -$2.54M | ﹤0.01% | 1571 |
|
|
2023
Q1 | $2.22M | Sell |
58,004
-20
| -0% | -$765 | 0.01% | 926 |
|
|
2022
Q4 | $3.18M | Buy |
+58,024
| New | +$3.18M | 0.01% | 788 |
|
|
2022
Q3 | – | Sell |
-128,087
| Closed | -$1.21M | – | 2139 |
|
|
2022
Q2 | $1.21M | Buy |
128,087
+128,073
| +914,807% | +$1.21M | ﹤0.01% | 1069 |
|
|
2022
Q1 | $1K | Buy |
+14
| New | +$1K | ﹤0.01% | 2056 |
|
|
2021
Q1 | – | Sell |
-32,830
| Closed | -$847K | – | 2212 |
|
|
2020
Q4 | $847K | Sell |
32,830
-5,787
| -15% | -$149K | ﹤0.01% | 1384 |
|
|
2020
Q3 | $1.19M | Buy |
38,617
+38,538
| +48,782% | +$1.19M | ﹤0.01% | 1177 |
|
|
2020
Q2 | $2K | Buy |
+79
| New | +$2K | ﹤0.01% | 2070 |
|